Boardroom Alpha
Boardroom Alpha
MC · Current Report (Form 8-K) · Filed June 6, 2025

Moelis & Co — Current Report (Form 8-K)

Form
8-K
Filed
June 6, 2025
Period
Jun 5, 2025
Ticker
MC
Accession
0001193125-25-137161
Boardroom Alpha · Filing insights

Five directors elected; advisory say-on-pay approved; Deloitte & Touche ratified as auditor for 2025.

About Moelis & Co
Market cap
$5.4B
1Y TSR
+15.1%
3Y TSR
+19.6%
Board grade
C+
Sector
Financial Services
CEO
Kenneth Moelis
Last annual meeting: Jun 25, 2026 · View full Moelis & Co profile →
8-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 06, 2025 (June 05, 2025)

 

 

 

LOGO

Moelis & Company

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-36418   46-4500216
(State or Other Jurisdiction
of Incorporation)
 

(Commission

File Number)

  (IRS Employer
Identification No.)

 

399 Park Avenue

4th Floor

 
New York, New York   10022
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s Telephone Number, Including Area Code: 212 883-3800

 

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Class A Common Stock   MC   The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 5.07

Submission of Matters to a Vote of Security Holders.

(a) On June 6, 2024, Moelis & Company (the “Company”) held its 2024 Annual Meeting of Stockholders (the “Annual Meeting”). (b) At the Annual Meeting, stockholders voted on proposals to (1) elect five directors to the Company’s board of directors; (2) approve, on an advisory basis, the compensation of the Company’s named executive officers; and (3) ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025. Following is the final tabulation of votes cast at the meeting.

Proposal 1:

Five directors were elected to the board of directors, based upon the following final tabulation of votes:

 

Nominee

   Votes For      Votes Against      Abstain      Broker Non-Votes  

Kenneth Moelis

     105,050,801        1,832,746        18,876        6,378,591  

Eric Cantor

     101,893,915        4,987,224        21,284        6,378,591  

Louise Mirrer

     100,718,038        6,164,823        19,562        6,378,591  

Kenneth L. Shropshire

     89,122,211        17,752,192        28,020        6,378,591  

Laila Worrell

     91,065,343        15,817,674        19,406        6,378,591  

Proposal 2:

The non-binding, advisory vote on the compensation of the Company’s named executive officers was approved, based upon the following final tabulation of votes:

 

For

     82,139,375  

Against

     24,628,012  

Abstain

     135,036  

Broker Non-Votes

     6,378,591  

Proposal 3:

The appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2025 was ratified, based upon the following final tabulation of votes:

 

For

     110,769,178  

Against

     2,486,856  

Abstain

     24,980  

Broker Non-Votes

     0  

(c) Not applicable.

(d) Not applicable.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits:

 

Exhibit
Number
   Description
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      MOELIS & COMPANY
Date: June 06, 2025     By:  

/s/ Osamu Watanabe

    Name:   Osamu Watanabe
    Title:   General Counsel and Secretary
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Moelis & Co (MC)

Reference

Frequently asked questions

When did Moelis & Co file this 8-K?
Moelis & Co (MC) filed this Current Report (Form 8-K) with the SEC on June 6, 2025. The accession number assigned by EDGAR is 0001193125-25-137161.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Five directors elected; advisory say-on-pay approved; Deloitte & Touche ratified as auditor for 2025. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Moelis & Co's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Moelis & Co has filed under CIK 1596967, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer